In Vivo, Journal Year: 2024, Volume and Issue: 39(1), P. 367 - 374
Published: Dec. 31, 2024
Dysregulation of claudin 6 (CLDN6) expression has been widely documented in various malignancies. CLDN6 is aberrantly expressed many types human carcinomas; however, its clinical significance endometrial carcinoma seldom investigated. This study aimed to examine the immunohistochemical status low-grade, early-stage endometrioid (LGES-EEC) and assess clinicopathological significance.
Language: Английский
In Vivo, Journal Year: 2024, Volume and Issue: 39(1), P. 367 - 374
Published: Dec. 31, 2024
Dysregulation of claudin 6 (CLDN6) expression has been widely documented in various malignancies. CLDN6 is aberrantly expressed many types human carcinomas; however, its clinical significance endometrial carcinoma seldom investigated. This study aimed to examine the immunohistochemical status low-grade, early-stage endometrioid (LGES-EEC) and assess clinicopathological significance.
Language: Английский
Citations
0